MOUNTAIN VIEW, Calif., July 1, 2008 (PRIME NEWSWIRE) -- Pharsight Corporation (Nasdaq:PHST), a leading provider of software and strategic services designed to optimize clinical drug development, announced today that it was added to the Russell Microcap(r) Index when Russell Investments reconstituted its comprehensive family of U.S. and global equity indexes on June 27, 2008.
